AQB 1.09 AquaBounty Technologies, Inc.
| Range: | 0.815-4.03 | Vol Avg: | 29101 | Last Div: | 0 | Changes: | 0.04 |
| Beta: | 1.15 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Consumer Defensive | IPO: | Wed Jan 11 2017 | Empoloyees: | 104 | ||
| CUSIP: | 03842K200 | CIK: | 0001603978 | ISIN: | US03842K3095 | Country: | US |
| CEO: | Mr. David F. Melbourne Jr. | Website: | https://www.aquabounty.com | ||||
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow